These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 23737213)

  • 1. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
    Antonescu CR; Le Loarer F; Mosquera JM; Sboner A; Zhang L; Chen CL; Chen HW; Pathan N; Krausz T; Dickson BC; Weinreb I; Rubin MA; Hameed M; Fletcher CD
    Genes Chromosomes Cancer; 2013 Aug; 52(8):775-84. PubMed ID: 23737213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
    Lee SJ; Yang WI; Chung WS; Kim SK
    Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant.
    Puls F; Niblett A; Clarke J; Kindblom LG; McCulloch T
    Virchows Arch; 2015 Apr; 466(4):473-8. PubMed ID: 25680571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
    Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
    Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study.
    Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC
    APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric visceral epithelioid hemangioendothelioma, with extremity dermal deposits, unusual late recurrence on the nasal bridge, and TFE3 gene rearrangement.
    Thway K; Mentzel T; Perrett CM; Calonje E
    Hum Pathol; 2018 Feb; 72():153-159. PubMed ID: 28855107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
    Anderson WJ; Fletcher CDM; Hornick JL
    Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.
    Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR
    Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
    Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
    Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epithelioid hemangioendothelioma with TFE3 translocation in soft tissue:a clinicopathological study].
    Song QY; Zhu XM; Song GX; Li X; Fan QH; Zhang ZH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1151-1156. PubMed ID: 34619869
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytologic features of hepatic YAP1-TFE3 rearranged epithelioid hemangioendothelioma.
    Bourgeau M; Martinez A; Deeb KK; Reid MD; Lewis M; Point du Jour KS; Lai J; Shi Q
    Diagn Cytopathol; 2021 Dec; 49(12):E447-E452. PubMed ID: 34411462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases.
    Zhang HZ; Dong L; Wang SY; Yang XQ
    Ann Diagn Pathol; 2020 Jun; 46():151487. PubMed ID: 32151991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant WWTR1 gene fusions in epithelioid hemangioendothelioma-A genetic subset associated with cardiac involvement.
    Suurmeijer AJH; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
    Genes Chromosomes Cancer; 2020 Jul; 59(7):389-395. PubMed ID: 32170768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
    Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
    Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.
    Errani C; Zhang L; Sung YS; Hajdu M; Singer S; Maki RG; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2011 Aug; 50(8):644-53. PubMed ID: 21584898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.
    Dermawan JK; Azzato EM; Billings SD; Fritchie KJ; Aubert S; Bahrami A; Barisella M; Baumhoer D; Blum V; Bode B; Aesif SW; Bovée JVMG; Dickson BC; van den Hout M; Lucas DR; Moch H; Oaxaca G; Righi A; Sciot R; Sumathi V; Yoshida A; Rubin BP
    Mod Pathol; 2021 Dec; 34(12):2211-2221. PubMed ID: 34381186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases.
    Flucke U; Vogels RJ; de Saint Aubain Somerhausen N; Creytens DH; Riedl RG; van Gorp JM; Milne AN; Huysentruyt CJ; Verdijk MA; van Asseldonk MM; Suurmeijer AJ; Bras J; Palmedo G; Groenen PJ; Mentzel T
    Diagn Pathol; 2014 Jul; 9():131. PubMed ID: 24986479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinctive subset of PEComas harbors TFE3 gene fusions.
    Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
    Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
    Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.